Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen
- PMID: 9493977
- DOI: 10.1023/a:1005872132373
Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen
Abstract
Leuprolide, a gonadotropin releasing hormone agonist, is currently being evaluated in a pilot study of premenopausal women for the prevention of breast cancer. However, little data is available regarding the efficacy of leuprolide in experimental animal models of carcinoma when administered prior to the carcinogen. In the present study the capacity of leuprolide to prevent tumor development was evaluated by comparing its pretreatment effects in the DMBA-induced rat mammary carcinoma model to pretreatment with tamoxifen and oophorectomy. Fifty-five day old, female Sprague-Dawley rats were randomly allocated to one of four groups: 1) no treatment; 2) oophorectomy two weeks prior to DMBA; 3) leuprolide, 40 microg/kg/day; and 4) tamoxifen, 10 mg/kg/week. All animals received four 5 mg doses of DMBA for a total dose of 20 mg. Leuprolide and tamoxifen treatments began two weeks prior to DMBA and ended one week after DMBA administration. Animals were assessed weekly to determine palpable tumor onset, number, size, and volume. At the conclusion of the study (16 weeks), autopsies were performed and tumor tissue was collected for confirmation of malignancy. Seventy-eight percent of the untreated rats developed tumors. No tumors developed in the oophorectomy group, while the number of rats with tumors was significantly reduced (p<0.05) with both leuprolide (30%) and tamoxifen (21.9%) compared to controls (77.8%). There were no significant differences in the tumor number for each tumor-bearing rat or in tumor volume between treated and control groups. Using our dosage regimen, 'chemical oophorectomy' with leuprolide was not as effective as surgical oophorectomy in the prevention of chemical carcinogenesis by DMBA but was comparable to the results obtained with tamoxifen.
Similar articles
-
Prevention of rat mammary carcinoma utilizing leuprolide as an equivalent to oophorectomy.Breast Cancer Res Treat. 1999 Nov;58(2):131-6. doi: 10.1023/a:1006383701051. Breast Cancer Res Treat. 1999. PMID: 10674877
-
Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats.Eur J Surg Oncol. 1996 Dec;22(6):583-7. doi: 10.1016/s0748-7983(96)92268-4. Eur J Surg Oncol. 1996. PMID: 9005144
-
The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.Int J Mol Med. 1999 Aug;4(2):145-8. doi: 10.3892/ijmm.4.2.145. Int J Mol Med. 1999. PMID: 10402480
-
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.Breast Cancer Res Treat. 1983;3 Suppl:S73-86. doi: 10.1007/BF01855131. Breast Cancer Res Treat. 1983. PMID: 6423014 Review.
-
Chemosuppression of breast cancer with long-term tamoxifen therapy.Prev Med. 1991 Jan;20(1):3-14. doi: 10.1016/0091-7435(91)90002-l. Prev Med. 1991. PMID: 2008427 Review.
Cited by 7 articles
-
Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.Front Pharmacol. 2018 Jun 20;9:650. doi: 10.3389/fphar.2018.00650. eCollection 2018. Front Pharmacol. 2018. PMID: 29973879 Free PMC article.
-
Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.Oncotarget. 2016 Jun 28;7(26):39097-39107. doi: 10.18632/oncotarget.9772. Oncotarget. 2016. PMID: 27259243 Free PMC article.
-
Role of RUNX2 in Breast Carcinogenesis.Int J Mol Sci. 2015 Sep 2;16(9):20969-93. doi: 10.3390/ijms160920969. Int J Mol Sci. 2015. PMID: 26404249 Free PMC article. Review.
-
Role of estrogen in hepatocellular carcinoma: is inflammation the key?J Transl Med. 2014 Apr 8;12:93. doi: 10.1186/1479-5876-12-93. J Transl Med. 2014. PMID: 24708807 Free PMC article. Review.
-
Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.Cell. 2012 Jan 20;148(1-2):72-83. doi: 10.1016/j.cell.2011.11.026. Cell. 2012. PMID: 22265403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources